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Molecular motion regulates the activity of the
Mitochondrial Serine Protease HtrA2
Matthew Merski1,5, Cátia Moreira2, Rui MV Abreu3, Maria João Ramos2, Pedro A Fernandes2, L Miguel Martins4,
Pedro José Barbosa Pereira1 and Sandra Macedo-Ribeiro*,1
HtrA2 (high-temperature requirement 2) is a human mitochondrial protease that has a role in apoptosis and Parkinson’s disease.
The structure of HtrA2 with an intact catalytic triad was determined, revealing a conformational change in the active site loops,
involving mainly the regulatory LD loop, which resulted in burial of the catalytic serine relative to the previously reported structure
of the proteolytically inactive mutant. Mutations in the loops surrounding the active site that significantly restricted their mobility,
reduced proteolytic activity both in vitro and in cells, suggesting that regulation of HtrA2 activity cannot be explained by a simple
transition to an activated conformational state with enhanced active site accessibility. Manipulation of solvent viscosity
highlighted an unusual bi-phasic behavior of the enzymatic activity, which together with MD calculations supports the importance
of motion in the regulation of the activity of HtrA2. HtrA2 is an unusually thermostable enzyme (TM= 97.3 °C), a trait often
associated with structural rigidity, not dynamic motion. We suggest that this thermostability functions to provide a stable scaffold
for the observed loop motions, allowing them a relatively free conformational search within a rather restricted volume.
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HtrA (high-temperature requirement) proteins, named for the
inability of deletion mutants to survive elevated temperatures,
are widely distributed throughout nature. They maintain protein
quality in the periplasmic space of Gram-negative bacteria or in
the intermembrane space of the mitochondria in animals and
plants.1–3 HtrAs are homo-trimeric enzymes, with each subunit
composed of a serine protease domain and one or more
regulatory PDZ domains.1 The protease domain, structurally
conserved in this family, has a chymotrypsin-like fold and several
flexible loops – including the surface loops 1-3 (L1-L3), and loops
A-D (LA-LD)4 – that have critical roles in substrate specificity and
allosteric regulation.1,5 Unlike trypsin, which is activated by a
proteolytic event that induces a disorder/order transition,1
regulation of HtrA proteases has been linked to (i) ligand
binding,2 typically small hydrophobic peptides to the PDZ
domain,6–8 or (ii) increased temperature.9,10
The human mitochondrial protease HtrA2 (also known as
Omi or PARK13) can be released into the cytosol,11 where it
cleaves inhibitor of apoptosis proteins facilitating caspase-
dependent apoptosis.3 In addition, HtrA2 has been associated
with several neurodegenerative disorders.12,13 Althoughmulti-
ple structural studies have provided an overall view of the
molecular architecture of human HtrA2,6,14 the exact mechan-
ism by which the enzyme is activated remains unclear. The
structure of human HtrA2 catalytic serine mutant S306A,
showed the PDZ packing against the protease domain.14
Movement of the PDZ domain, facilitated by increased
temperature or by PDZ-binding peptides,7,10 was proposed
to activate HtrA2, similar to the allosteric mechanism
suggested for the regulation of bacterial DegS.15 The main
structural difference between HtrA2 and DegS resides in the
catalytic site of DegS being continually exposed, whereas the
‘inactive’ resting state is stabilized by interactions at the
interface between the PDZ and the protease domain, which
are modified upon enzyme activation.15 However, in DegS, the
specific interactions between the activating peptide and the
protease domain are variable and not conserved between
different peptides.16 The variable role played by the PDZ
domain in the activation of the different HtrA proteases
suggests that additional features might contribute to the
activation mechanism.14,17–20
Here, the structure of the active form of humanHtrA2 protease
with a complete catalytic triad (HtrA2/WT) is reported. The
catalytic triad of active HtrA2, which shows conformational
plasticity, is predominantly found in a catalytically incompetent
arrangement. The HtrA2/WTactive site is significantly occluded
by a LD loop conformation different from that of the HtrA2/S306A
structure.14 Mutational studies, combined with structural and
molecular dynamics analysis, and the effect of viscosity in HtrA2/
WTactivity, suggest that motion in the LD and L1 loops is critical
for HtrA2 proteolytic activity.
Results
Structure of wild-type HtrA2. The structure of the mature
form of HtrA2/WT was determined to a resolution of 1.65 Å
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(Supplementary Information Table 1; Figure 1). The structure
is very similar (Cα RMSD 0.7 Å) to the previously determined
structure of HtrA2/S306A14 (Supplementary Information
Table 2). Remarkably, the HtrA2/WT structure revealed a
rearrangement of the loops around the protease active site
that buried the catalytic serine. Large conformational
changes are observed within loop LD and active site loop
L1 (Figure 1a; Supplementary Information Figure 1). The
main-chain α-carbon of LD loop residue Q267 is 6 Å closer to
active site loop L1, restricting access to catalytic S306 by
shifting F303 (Figures 1b and c). The PDZ domain of the
neighbor subunit is closer to the LD and L1 loops, further
occluding the access to the active site (Supplementary
Information Figure 2A). These changes lead to a partial
closure of the access to the protease catalytic site
(Figures 1b and c). This ‘Buried’ conformation, partially owing
to rearrangements of F303, Q267 and the LD loop, is
observed in both HtrA2/WTand mutant HtrA2 structures (see
Supplementary Information). The LD loop is in direct (o4 Å)
contact with the α1* helix (residues 371*–380*; * indicates an
adjacent subunit) of the neighbor PDZ* domain (Figure 2a).
There are polar interactions between the PDZ* domain R380*
and D302 in loop L1, and a hydrophobic interaction between
L379* and F303 (Figure 2a). This network of interactions
delineates the communication path from the PDZ regulatory
peptide-binding region (YIGV motif; Supplementary
Information Figure 1) to the active sites across HtrA2 subunits
(Figure 2a). In this ‘Buried’ conformation, a structural
rearrangement is critically required for the peptide substrates
to access the protease active site, involving the coordinated
movement of loops L1 and LD and the PDZ domains on
adjacent subunits across the quaternary HtrA2 interface.
Active site remodeling in wild-type HtrA2. The catalytic
triad in HtrA2/WT is distorted, with H198 facing away from
S306. The hydroxyl moiety of S306 establishes hydrogen
Figure 1 Structural rearrangement of active site loops in wild-type HtrA2. (a) Stereo diagram of the HtrA2/WT monomer in cartoon representation. For comparison, the loops
around the active site whose conformation is changed in the HtrA2/S306A mutant are superposed (LA= orange, L1= blue, L2= cyan, L3= pink, LD= red, PDZ
domain= salmon, protease domain= green). Specific residues in HtrA2/WTare labeled and residues S142, S276 and G399 are shown in space-filling representation; # denotes
residues that shift position in HtrA2/WT. Amino-acid sequence numbering is based on full-length immature human HtrA2.14 (b, c) Surface representation of the trimeric assembly
of HtrA2/WT (this work, herein referred to as the ‘Buried’ conformation) and the HtrA2 S306A mutant (PDB entry 1lcy,14 herein referred to as the ‘Exposed’ conformation). As in
panel a the PDZ domain is shown in salmon, whereas the protease domains are shown in white, pale blue and pale green to visually differentiate the separate monomeric units
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bonds with N196 side-chain and with T322 main-chain
carbonyl (Figure 2b). The third residue composing the
catalytic triad, D228, is shifted away from H198 and forms a
single hydrogen bond with the main-chain nitrogen of A197.
Importantly, the K395 side-chain from the PDZ domain
establishes a water-mediated interaction with T322, and
stacks between F303 and H198, inducing a concerted
movement of the PDZ towards the HtrA2 active site
(Figure 2a; Supplementary Information Figure 2B). The
F303 carbonyl shifts by 1.8 Å towards the active site,
stabilizing the new loop L1 conformation. The protease
oxyanion-binding site is distorted, as often observed in HtrA
enzymes.21,22 The catalytic H198 also evidences disorder
(Supplementary Information Figure 2B), being observed in an
active rotamer in four of the six HtrA2 structures herein
determined (Supplementary Information Figure 2B). There-
fore, restoring the proteolytic triad in HtrA2/WT disrupted the
geometry of the active center and HtrA2/WTwas crystallized
in a resting state with a catalytically incompetent
conformation.
Molecular dynamics simulations of HtrA2. The conforma-
tional plasticity around the HtrA2 catalytic site was further
explored using MD simulations. The modeled structures (WT-
S306Amodel and S306A-A306Smodel) and the two X-ray
crystal structures (HtrA2/WT and HtrA2/S306A) were sub-
jected to MD simulations of 200 ns. In the simulation with the
HtrA2/WT structure, H198 remained in the catalytically
incompetent position (as observed in the wild-type crystal
structure) most of the time, only transiently occupying the
active conformation. In agreement with the experimental
data, in the HtrA2/S306A structure the H198 side chain
maintained the catalytically competent conformation
observed in the experimental data during the whole simula-
tion. In the WT-S306Amodel system the H198 side-chain
changed from the catalytically incompetent to the active
rotamer during the 200 ns of simulation or, in the case of
chain A, during energy minimization before the 200 ns MD
simulation, and maintained that conformation during the
entire simulation. In the S306A-A306Smodel simulation, the
conformation of the catalytic triad was kept mainly in a
catalytically competent conformation. However, during the
simulation, the side-chain of H198 moved away from S306,
together with the catalytic D228, although it did not complete
the full shift to the conformation observed in the crystal
structure of HtrA2/WT. In summary, the presence of a serine
residue in position 306 favors an inactive conformation of
H198, thereby perturbing the geometry of the active site.
Figure 2 LD and L1 loops interconnect the PDZ domains across adjacent HtrA2 subunits. (a) The intersubunit interface in HtrA2/WT highlights the key role of L1 (through
D302) in the communication between the catalytic site and both the LD loop and helix α1 on the PDZ domain of the adjacent subunit (* indicates residues in a neighbor subunit).
The PDZ regulatory peptide-binding region (YIGV motif) is shown in magenta. (b) A network of polar interactions centered on the S306 side-chain reorients the active site loops
and partially occludes the access to the protease active site (catalytic triad residues labeled in red). Dashed lines represent putative hydrogen bonds cross-linking the L1 and LD
loops in panel a), and centered on the active site S306 in panel b. (c) Free-energy profile along the rotation of the C-Cα-Cβ-Cγ dihedral of H198 for the HtrA2/WT (green) and
S306A (pink) structures. The rotamers at the two free-energy minima (−65° and 85°) are shown, with the atoms forming the dihedral angle highlighted by a black dashed line
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To provide quantitative details on the conformational
plasticity of the HtrA2 active site, the free-energy profile for
the rotation of the H198 side chain along the C-Cα-Cβ-Cγ
dihedral was calculated with umbrella sampling MD, in both
the WT and the S306A structures. The free-energy profile
(Figure 2c) shows two stable dihedral angles (circa 85° and
−65°), corresponding to the values seen in the two experi-
mental structures. The more stable dihedral in the HtrA2/WT
X-ray structure has a value of 85°, explaining the prevalence of
such ‘inactive’ conformers in the crystal structure (detailed
description in Supplementary Information).
Molecular dynamics simulations of conformational
changes around the active site of HtrA2. Major conforma-
tional changes were observed between the crystal structures
of HtrA2/WT and HtrA2/S306A, in loop LD and for F303,
accompanied by a motion of the PDZ domain toward the
catalytic site. No major changes were observed in the
simulations that started from the HtrA2/WT structure, as
expected, as the transition of loop LD from the ‘Buried’
(HtrA2/WT) to the ‘Exposed’ (HtrA2/S306A) conformation
would result in a clash between Q267 and residues in PDZ*.
The LD loop shifted to a position similar to the one found in
the HtrA2/WT X-ray structure (‘Buried’ conformation) in both
simulations that started from structures with the S306A
mutation (HtrA2/S306A crystal structure and S306A-
A306Smodel), with residue F303 consistently moving between
the ‘Exposed’ and ‘Buried’ conformations. This result
suggests that the loop is free to sample both conformations
and that over a much longer timescale the movement of the
loop LD back and forth between the two conformations may
be observed.
The position of the PDZ domain relative to the protease
domain also changed in the HtrA2/WT structure. In fact,
reorganization of the catalytic triad geometry is related to a
motion of the PDZ domain towards the protease domain,
centered on the water-mediated interaction between the K395
side chain and the T322 carbonyl. To investigate the role
played by this movement of the PDZ domain on the
conformational changes of loop LD, two additional models
were built, by direct replacement of the PDZ domains (WT-
PDZS306Amodel and S306A-PDZWTmodel). Both models were
subjected to 200 ns MD simulations. The results strongly
suggested that the PDZ domain indeed influences the position
of both the LD loop and the F303 side chain. In the WT-
PDZS306Amodel a spontaneous and gradual transformation of
the LD loop conformation from the ‘Buried’ to the ‘Exposed’
conformation was observed, while in the simulations of the
S306A-PDZWT model, the LD loop gradually and sponta-
neously changed to a conformation resembling the one in the
HtrA2/WT crystal structure with F303 occluding the active site,
demonstrating the high flexibility of these conformations.
Engineering ‘Exposed’ and ‘Buried’ HtrA2 conforma-
tions. To analyze the effect of active site exposure on the
proteolytic activity of HtrA2, mutations were introduced to
favor either the ‘Exposed’ conformation of the LD loop
observed in S306A (Figure 1c) or the ‘Buried’ conformation
observed in the WT structure (Figure 1b). In brief, the HtrA2/
Open construct contained the mutation L266R to create
hydrogen bonds with helix α1* of the neighboring PDZ
domain, as well as the space-making F303A mutation,
whereas the HtrA2/Closed construct introduced N181S and
mutations Q267R, N268A, T269E to create hydrogen-
bonding interactions to favor the ‘Buried’ LD loop conforma-
tion. These efforts were greatly aided by the inherent stability
of HtrA2, which melts above 95 °C (Supplementary
Information Figures 3 and 4), an unusually high temperature
for a cytosolic human protein.23 The structure of the active
conformation-favoring HtrA2/Open mutant was determined at
1.69 Å resolution (Supplementary Information Table 1). The
LD loop and catalytic triad are in the same basic conformation
in both the wild-type and the HtrA2/Open structures. In HtrA2/
Open the space-making F303A mutation increases the
exposure of the active site S306 residue (Supplementary
Information Figures 2A). MD simulations of the HtrA2/Open
construct suggest that R266 is highly mobile, but the L1 and
LD loop conformations were unchanged during the 200 ns
MD simulation (Supplementary Information movie 1). MD
simulations also showed that, in the absence of the aromatic
side chain of F303, Q267 shifted toward loop L1, restricting
its mobility and enhancing active site accessibility
(Supplementary Information Figure 5A).
TheHtrA2/closed construct could not be crystallized, but the
mutations (N181S, Q267R, N268A, T269E) were modeled
and MD calculations were carried out to explore the dynamics
of the loops surrounding the active site. The modeling and MD
simulations of the HtrA2/Closed structure suggest the estab-
lishment of a strong interaction between S181 and R267
(Supplementary Information Figure 5B). Another strong
contact is established by mutation T269E, that interacts with
R380* of the α1* helix from the neighboring PDZ domain.
These interactions affect the mobility of the LD loop,
which remained locked in its initial position for the whole
simulation, whereas the active site remained mostly buried
(Supplementary Information Figure 5B, Supplementary
Information movie 2).
Both sets of mutations that were originally designed to favor
specific conformational states either exposing or hindering the
catalytic site were highly detrimental to the protease activity of
HtrA2, reducing it by 2000- and 15 000 fold for the HtrA2/
Closed and HtrA2/Open mutants, respectively
(Supplementary Information Table 3). This loss of activity
was also mirrored by a significant reduction in the ability of
these mutants to induce cell death when transiently trans-
fected into U2OS cells (Figure 3). In every case – including
S306A – the catalytic serine would be considered buried by
convention,24 but the substrate was still able to enter the active
site and be hydrolyzed in HtrA2/WT, although curiously less
efficiently in mutants that have more open active sites
(Supplementary Information Table 3). Taken together, these
results suggest that simply favoring a more exposed con-
formation of the catalytic triad does not lead to increased
HtrA2 enzymatic activity. MD simulations with HtrA2/WT and
the two designed constructs suggested that the engineered
mutations in both HtrA2/Open and HtrA2/Closed decrease the
mobility of the loops surrounding the enzyme active site
(Supplementary Information Figure 5; Supplementary
Information movies 1-3).
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A search of the PDB for other HtrA enzymeswith a protease
domain and at least one PDZ found 26 additional structures
(see Supplementary Information). All the structures were
aligned by the PDZ domain and pairwise comparisons of the
distances between the Cα atoms of the catalytic serine were
made and then clustered into at least five groups (Figure 4).
The lack of an obvious factor that gave rise to the groups
suggests the conformations are largely stochastic (animated
as Supplementary Information movie 4).
The effect of viscosity on HtrA2 activity. To assess the
role of dynamic motion in HtrA2 proteolytic activity, the
enzymatic activity of HtrA2 was measured at different solution
viscosities. Increasing solution viscosity by addition of the
microviscogen glycerol increased both HtrA2/WT and
HtrA2 ΔPDZ activity (Figure 5a).25 This observation is in
contrast to the traditionally observed activity decrease at high
viscosity for enzymes that have a viscosity dependence.25
The mean kcat/KM value is 12-fold greater at a moderate
relative viscosity η= 2.4–3.5 for HtrA2/WT, whereas the mean
activity increase for ΔPDZ HtrA2 achieved a maximum of
ninefold increase at η= 2.4. A 1:1 correlation between relative
viscosity (η) and relative activity is typically considered good
evidence for viscosity dependence in enzyme activity,25 a
value that both HtrA2/WT and ΔPDZ mutant exceed at
moderate viscosities (Figure 5). Increasing the solution
viscosity beyond moderate values resulted in reductions in
kcat/KM from the observed maxima, more in line with
traditionally expected behavior.25 Similar results were also
observed for the HtrA2 mutants (Supplementary Information
Figure 6). In the presence of a larger viscogen, PEG 8000,
the proteolytic activity of HtrA2/WT and HtrA2 ΔPDZ
decreased with increasing solution viscosity, which is also
indicative of the role of dynamic motion in catalytic activity
(Figure 5b). Notably, both chemically different viscogens
reduce HtrA2 proteolytic activity at high viscosities (η43.5),
as expected for enzymes in which protein conformational
change plays a role in activity.25,26
Discussion
Although there are numerous reports of observed transitions
in HtrA enzymes between ‘active’ and ‘inactive’ states,1,8,9,27 a
simple two-state model cannot account for the observed
behavior of HtrA2. Counter to expectations, the crystal
structures and MD simulations of HtrA2 both demonstrate a
preference for greater steric occlusion of the active site in the
WT enzyme compared with the S306A inactive mutant.
Mutations designed to stabilize a single conformation of the
LD loop led to significant losses in activity (Supplementary
Information Table 3), suggesting that locking HtrA2 into a
single conformational state is not conducive to its function, a
property that has been noted in other HtrA proteins16,20 and
other proteases.26 Although there is a generally accepted
active arrangement for the catalytic triad of serine proteases,
analysis of the orientations of the PDZ domain with respect to
the protease domain reveal at least five conformations
(Figure 4). No PDZ orientation could be definitively correlated
with the ‘active’ conformation in DegP,28 nor was there any
obvious conservation of contacts with the protein in the
structures of a set of 14 DegS ligands.16 The large number of
orientations observed between these two domains in struc-
tures of HtrA proteases, as well as the lack of any over-arching
causative factor that would favor any given orientation
suggests a significant degree of stochasticity in these
conformations. In addition, increased solution viscosity
significantly modified proteolytic activity in HtrA2/WT and
mutants, indicating that normal HtrA2 activity includes a
significant protein motion component, as confirmed by MD
simulations of HtrA2 (Supplementary Information Figure 5 and
Supplementary Information movies 1-3).
HtrA structures generally require rearrangements to
achieve optimally active conformations. The catalytic
triad in the HtrA2/WT structure is disrupted, with the nearest
accessible H198 side chain atom positioned 5.9 Å away from
the carboxylate oxygen of D228 and separated from the
hydroxyl of S306 by 7.4 Å, requiring substantial rearrange-
ments to re-establish a catalytically competent conformation
(Supplementary Information Figure 2). Distorted geometries
of the catalytic triad resulting from unusual rotamer con-
formations of the active site histidine side chain have also
been observed in Escherichia coli DegS15 and human
HtrA1.29 Structures of DegS with activating peptides have
failed to demonstrate a consensus set of activating interac-
tions between the peptide and the protease domain,
suggesting that activation does not occur by locking in a
specific active conformation.16 The paralogous human
protein, HtrA1, is also known to be conformationally flexible
in solution: six reported HtrA1 monomers display different
active site conformations,29 and their PDZ domains are
disordered in crystal structures of the mature protease.30
These observations point to the role that dynamics have in
HtrA2 function, as noted previously.5,10,21,31,32
Figure 3 Mutations in the LD loop prevent HtrA2-induced cell death. (a)
Mutations that favor either the exposure or burial of the catalytic site (Figure 1) greatly
reduce cell death upon HtrA2 expression in U2OS cells. Each data point represents a
separate biological replicate while bar height represents the mean value of all three
measurements. (b) Representative micrographs showing U2OS cells dually
expressing HtrA2 and GFP (green), both viable and dead (indicated by DRAQ7
staining, red). Expression of HtrA2/WT in the cytoplasm (top right) visibly induces
(correlation of green GFPexpression and red cell death indicator DRAQ7) much more
cell death than when HtrA2/Open, containing LD mutations, is expressed
(bottom right)
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Large-scale, stochastic protein rearrangements occur in
HtrA proteins. Although only small changes are observed in
the relative positions of the HtrA2 protease and PDZ
domains, the HtrA family as a whole undergoes massive
(4100 Å) orientational changes (Figure 4; Supplementary
Information movie 4). Although the number of possible
causes for these changes relative to the number of structures
available (n= 32) precluded a truly stringent statistical
analysis, the lack of obvious causes and the considerable
space sampled by these movements suggests that these
large-scale rearrangements are largely stochastic, compar-
able to the small-scale active site movements of proteins in
solution, which are observed in the MD simulations of HtrA2
and in a report of gradual relaxation and expansion coupled
with a complex set of changes in HtrA2 with increasing
temperature.10
Direct evidence for motion in HtrA2. Upon observing
conformational changes in the LD loop (F264-S272) and
F303 on loop L1 in the crystal structures of HtrA2, a two-state
transition between an enzymatically active state and an
inactive (resting) state was initially assumed, as has been
previously proposed for other HtrA enzymes.9,15,27 However,
this interpretation raised several issues. First, the active site
residue S306 is more solvent exposed in the inactive HtrA2/
Open mutant than in the active HtrA2/WT (Figure 1,
Supplementary Information Figure 2C). Second, LD loop
mutations that decrease the proteolytic activity in HtrA2/Open
and HtrA2/Closed significantly constrain the dynamics of
the loops surrounding the active site, as observed in
MD simulations (Supplementary Information movies 1-3).
Mutations in the LD loop also drastically reduce protease
activity in DegS33 and have been recently shown to modulate
human HtrA2 activity.6 In addition, the expected primary
importance of a specific ‘active’ conformation is in contrast to
the often-reported increase in activity of the protease at
higher temperatures, where conformational flexibility is
expected to increase.9,10 It could be argued that the
increased flexibility allows easier barrier crossing into the
active conformation, but the observation of these conforma-
tions in both liganded and unliganded structures
(Supplementary Information Table 4) suggests otherwise.
Third, the proteolytic activity of HtrA2 is clearly affected by
changes in solution viscosity (Figure 4), both by the small
molecule glycerol (RH=3.1 Å)
34 and the much larger PEG
8000 (RH=27.5 Å),
35 suggesting a dependence on dynamic
motion for proteolytic activity.25,36 It is unlikely that this
dependence is due to binding of glycerol as an allosteric
ligand, as there was no clear evidence of glycerol in any of
the six experimental structures here reported despite its
inclusion in the crystallization solutions. As the effect of
solvent viscosity on protease activity is bimodal, changing
from activity increasing at moderate viscosities to more
traditional activity inhibition at high viscosities (Figure 5), it is
unlikely to result from bulk solvent effects such as protein
hydration. Furthermore the much larger, chemically different
molecule, PEG 8000, also affects activity. Interestingly, the
bimodal dependence on viscosity suggests that there are
both classical activity-enhancing25 and activity-suppressing
motions that are functionally important in HtrA2. Although
activity-suppressing effects in HtrA proteins have been linked
to the PDZ domain,8,14 activity-enhancing effects have
Figure 4 Relationship between the relative orientations of PDZ domains in HtrAs organized by complete linkage hierarchical clustering. (a) Tree plot showing the relationship
between the PDZ domain orientation and the protease active site in HtrA proteins in the PDB, which appear to fall into at least five groups. The grouping was generated by
hierarchical clustering using complete linkage of the pairwise distances between the Cα carbon of the catalytic serine residues. Structures were grouped at an arbitrary cutoff of
20 Å (red line). (b) Heatmap representation of the pairwise spatial distance between the catalytic residues of HtrA protein structures in the PDB when the PDZ domains are
superposed. PDB entry code is given for each group member inside parentheses. The names used for HtrA2 structures from this report are also given where appropriate. The five
groupings are also clearly visible from this representation as similar (warm, red) relationships can be readily distinguished from further (cool, blue) ones in the heatmap
Figure 5 Effect of viscosity on HtrA2 proteolytic activity. For clarity this graph shows the ratio of (kcat/KM)/ (kcat/KM)
0, which better indicates increased enzymatic activity than
the standard (kcat/KM)
0/(kcat/KM) that best represents suppressive viscosity effects, thus leading to an inverse fit line. The dashed line indicates the traditionally expected 1:1
antagonistic relationship between viscosity and enzyme activity.63 The solid blue line at (kcat/KM)/ (kcat/KM)
0= 1 is the expected result if there is no correlation between enzyme
activity and solution viscosity. (a) The effect of the microviscogen, glycerol, on HtrA2 proteolytic activity in 50 mM phosphate pH 8.0, 150 mM KCl. Note the offset axis as the effect
of viscosity on HtrA2 activity is quite significant. Each data point represents the mean value of a separate experiment. (b) Representation of the effect of the viscogen, PEG 8000,
on HtrA2 proteolytic activity in 50 mM phosphate pH 8.0, 150 mM KCl. Each data point is the mean value of a measurement performed in triplicate
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traditionally been attributed to the protein achieving a
catalytically optimal conformational state9 or increases in
temperature (e.g., increased molecular motion).9,10 All these
observations are consistent with dynamic protein motions
and, in fact, cannot be accounted for entirely by the
invocation of a simple activated ‘state’ of HtrA2. We suggest
that, much like the movements of a grandfather-style clock,
dynamic protein motions are important to HtrA protease
activity. Although snapshots (crystal structures) may find
certain conformations, the position of the pendulum can only
partially explain the function of the clock. Overall, these
results illustrate the essential role of dynamic motions in
HtrA2 activity, a feature that is likely shared by other HtrAs.
Materials and Methods
All reagents used were commonly commercially available except where
otherwise noted.
Cloning and protein expression. HtrA2/WT (Addgene plasmid #14126,
Cambridge, MA, USA), as well as the A141S (Addgene plasmid #16157), S142D
(Addgene plasmid #16154), G399S (Addgene plasmid #16158) and S276C point
mutants were purified as described.7 Further mutations to the HtrA2 gene were
introduced using the method of overlap extension37 and ligated into the pET-29
expression vector (Novagen, Darmstadt, Germany) using introduced restriction sites
NdeI and XhoI. Cloning into pET-29 resulted in the insertion of two extra residues
(leucine and glutamate) into the HtrA2/WT, HtrA2/Open, HtrA2/Closed and
HtrA2 ΔPDZ constructs used for activity and thermostability experiments, which
were not present in the crystal structure of HtrA2/WT. The additional residues did
not appear to change the quaternary structure of HtrA2 as assessed by native
PAGE. Amino-acid sequences for the proteins used in this work are given in
Supplementary Information Table 5. Plasmids containing HtrA2 variants were
transformed into E. coli BL21 (DE3) cells and grown at 37 °C with shaking in LB
medium containing kanamycin until an O.D.600= 0.5–0.7 was reached. The cultures
were then quickly cooled on ice, induced with 1 mM isopropyl β-D-1-
thiogalactopyranoside and grown overnight at 16 °C. Cells were then harvested
by centrifugation, frozen in liquid nitrogen and stored at − 80 °C until used. Cell
pellets were resuspended in 125 ml of lysis buffer (10 mM imidazole pH 7.0,
300 mM NaCl, 1% (v/v) Triton X-100) per liter of culture and lysed by sonication on
ice. Protease inhibitors were not used during protein purification. The lysate was
clarified by centrifugation at 15 000 × g for 40 min and applied to a HisTrap FF
column (GE Healthcare, Life Sciences, Freiburg, Germany). The column was
washed with 10–20 column volumes of 30 mM imidazole pH 7.0, 300 mM NaCl,
20% (v/v) glycerol, and the bound proteins eluted with 250 mM imidazole pH 7.0,
150 mM NaCl, 20% (v/v) glycerol. The eluted protein was concentrated with a
centrifugal ultrafiltration device (Millipore, Darmstadt, Germany; 10 kDa cutoff) and
then applied to a Sephacryl S-300 column (GE Healthcare) pre-equilibrated in HtrA2
storage buffer (50 mM Tris pH 8.0, 150 mM NaCl, 20% (v/v) glycerol). Fractions
containing HtrA2 were pooled, concentrated as described above, frozen in liquid
nitrogen, and stored at − 80 °C. Protein concentrations were determined using a
Direct Detect infrared spectrometer (Millipore).
Crystallization and structure determination. Crystals were grown
using the sitting drop vapor-diffusion method by mixing equal volumes of protein
(10–15 mg/ml) and reservoir solution (0.1 M MES pH 6.0, 1 M LiCl, 15–20% (w/v)
PEG 6000). Crystals grew to a typical size of 0.4 × 0.4 × 0.5 mm3 within 4–5 days at
20 °C. The crystals, belonging to space group H3 and containing one molecule in
the asymmetric unit, were cryoprotected by equilibration in crystallization buffer
supplemented with 25 % (v/v) glycerol and flash frozen in liquid nitrogen. Diffraction
data (each set from a single crystal) were collected at ESRF (Grenoble, France)
beamlines ID14EH3 and ID2938 and were processed with MOSFLM39 (WT, and
A141S, S142D, S276C and G399S mutants) or XDS40 (HtrA2/Open) and scaled
with SCALA.41 The structures were solved by molecular replacement using the
coordinates of HtrA2/S306A (PDB entry 1lcy14) as search model, refined with
PHENIX using TLS,42,43 and rebuilt manually using COOT.44 Crystals obtained for
HtrA2/WT and mutants A141S, S142D, S276C, and G399S were significantly
twinned and refined using the twin law h, -h-k, -l. Structures were checked for errors
using MolProbity.45 Figures were prepared with PyMOL (Schrödinger). There were
notable gaps in the electron density for the N- and C-termini, within the L3 loop
(between residues R280-V292 with small variations in the different structures), and
for the linker region between the protease and PDZ domains (G345-S357) common
for all the structures described in this work (Figure 1 and Supplementary
Information). For the structures here determined, all residues were in favored/
allowed regions of the Ramachandran plot. The refined coordinates and
corresponding structure factors were deposited at the Protein Data Bank with
accession codes 5m3n (wild-type), 5m3o (A141S mutant), 5tnz (S142D mutant),
5tny (G399S mutant), 5to0 (S276C mutant), and 5to1 (Open mutant).
HtrA2 functional assays. HtrA2 activity was measured using an artificial
fluorescent peptide substrate (H2-Opt) in a Molecular Devices Spectramax Gemini
XS fluorescence plate reader with temperature control (λexcite= 320 nm, λemit= 395
nm).7 The substrate (dissolved in DMSO) was diluted to assay concentrations of 7–
26 μM in assay buffer (100 mM buffer, 400 mM KCl, 20% (v/v) glycerol) for the pH
variation experiments. The concentration of DMSO never exceeded 1% (v/v) in the
assay. All reaction components (including HtrA2) were mixed and allowed to stand
for 10 min at the appropriate temperature before the reaction was started by
addition of the fluorogenic substrate.7 The buffers used for the pH variation
experiment were acetate (pH 5.0 and 5.7) and phosphate (pH 5.7–8.3). Controls
lacking HtrA2 were used to establish an endogenous rate of hydrolysis and this was
subtracted from the total rate observed in the presence of enzyme. Due to limits in
substrate solubility and the low binding affinity of the peptide substrate, analysis was
limited to the kcat/KM ratio. The mean kcat/KM values reported for a given
temperature for HtrA2/WT were determined from the mean values for that
temperature over a pH range of 6.7–8.3. The kcat/KM values reported for mutant
HtrA enzymes are the mean value of a set of measurements performed in triplicate
at 37 °C.
Viscosity measurements were performed in 50 mM Tris pH 8.0, 150 mM NaCl with
varying concentrations of viscogen (0–80 % (v/v) glycerol or 0–30 % (w/v) PEG 8000)
as above. Buffer viscosities were determined using a Myr Rotational viscometer V2–
V3000 at room temperature (19–23 °C) and normalized to the viscogen-free
control.25,46 The glycerol viscosity experiments for HtrA2/WT and HtrA2 ΔPDZ are
the mean values of three separate experiments performed in triplicate. For the
viscosity experiments, each graphical data point represents the mean value of a
separate experiment (n= 3 for WT & ΔPDZ with glycerol and n= 1 for all others).
Molecular dynamics simulations. The HtrA2/WTand S306A mutant (PDB
entry 1lcy14) crystallographic structures served as base for building models to
explore the conformational differences between these two structures. Eight models
were built, all as homotrimers containing chains A, B and C, with each chain being
formed by residues S142-Q279, E293-H343 and R359-E458. Of these eight
models, two (HtrA2/WTand S306A) were experimental X-ray structures. To analyze
the influence of the S306 hydroxyl moiety on the geometry of the catalytic triad two
models were prepared: WT-S306Amodel (S306A mutation was modeled in the HtrA2/
WT crystal structure) and S306A-A306Smodel (A306S mutation was modeled back
in the crystallographic structure originally carrying the S306A mutation). Two models
resulted from the introduction of the mutations that specifically favor the exposure or
burial of the active site. These correspond to L266R and F303A, in the HtrA2/Open
model, and N181S, Q267R, N268A and T269E, in the HtrA2/Closed model. The last
two models resulted from the substitution of the PDZ domain, by superposing the
protease domains and changing the PDZ domains from the wild-type structure to
the S306A structure (WT-PDZS306Amodel) and vice-versa (S306A-PDZWTmodel). In
the HtrA2/WT X-ray structure the PDZ domain is more distant from the protease
domain, whereas in the S306A crystal structure the PDZ domain is significantly
closer to the protease domain.
The protonation states of the residues were checked with the H++47 and
PROPKA48 webservers, and visually confirmed afterwards, with all residues falling
under the standard protonation states except residues H170, H389, H403 (which
were modeled as positively charged) and E376 (which was modeled as neutral). The
Leap extension of the Amber 12 package49 was employed to add all hydrogen atoms,
TIP3P water molecules (~30 000 water molecules) and counter ions (3 Na+) to
generate neutral systems, inserted in octagonal water boxes of 15 Å. The FF12SB
force field50–52 was employed to describe the protein. Energy minimizations were
performed with the Sander module following a four-stage protocol. Harmonic
potentials (50 kcal/mol/Å2 force constant) were used at first to restrain the positions of
selected atoms in the systems, and later removed: stage 1 (500 steps) all atoms
except those from the water molecules were restrained; stage 2 (800 steps) the
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restraints on the hydrogen atoms were released; stage 3 (2500 steps) only the
backbone chain atoms were restrained; and stage 4 (6000 steps) all the system was
free. After fully optimizing the system, a MD of 20 ps was performed with the
temperature being raised from 0 to 300 K at constant volume, followed by simulations
of 200 ns (see below) at constant temperature and pressure (at 300K and 1bar,
controlled by Langevin thermostat53 and Berendsen barostat54). The time step used
was 2 fs. The SHAKE algorithm was used to fix the bond length between hydrogen
atoms and heavy atoms. The PMEMD (Particle Mesh Ewald Molecular Dynamics)
module was employed in these calculations, with a cutoff of 10 Å for both the short-
and the long-range interactions. The information collected from the 200 ns MD
simulations was analyzed with the CCPTRAJ module of AMBER 12 and visualized
with the VMD software.
Umbrella sampling calculations. The two X-ray structures (HtrA2/WT and
S306A mutant) were submitted to umbrella sampling MD calculations in order to
build up a free-energy profile for the rotation of the H198 C-Cα-Cβ-Cγ dihedral. The
geometry-optimized structure was the starting point for the calculations. The
temperature of the system was raised from 0K to 300K in a 20 ps MD simulation
(with similar conditions as those previously described, except that the H198 C-Cα-
Cβ-Cγ dihedral was fixed) with a 1 fs time step. The dihedral angle in the study was
initially fixed at 60° and then subsequently increased/decreased in 5° steps, until the
complete rotation (360°) was explored (72 simulation windows). The starting points
in each window were generated by a series of sequential short (100 ps) simulations
with a 0.12184 kcal/mol/deg2 harmonic force constant applied to the dihedral angle.
The 72 dihedral windows were then sampled for 10 ns, and analyzed by the
weighted histogram analysis method55 to obtain the free-energy profiles. The
umbrella sampling MD was performed with the PMEMD module, with the previously
described conditions for normal MDs. The uncertainty of free-energy profiles is not
easy to estimate, as it has both a statistical source (easy to calculate, here below
0.3 kcal/mol) and a source that comes from the inaccuracy of the force field
parameters, which is quite difficult to quantify. In most cases where direct
comparison with accurate experiments is possible, the errors in the computational
free energies in several different contexts lie ~ 1.1–1.5 kcal/mol, or around one order
of magnitude in equilibrium/rate constants.56–59
Cell-based apoptosis assay of HtrA2. U2OS cells were plated in 24-well
plates at a concentration of 3 × 104 cells/well in MEM medium (Gibco, Waltham, MA,
USA) with 0.5 % antibiotic antimycotic solution (SIGMA, St. Louis, MO, USA) at 37 °
C and allowed to attach overnight. Cells were transfected using Lipofectamine 3000
(Invitrogen, Waltham, MA, USA) with 1 μg of pIRES2-EGFP containing the HtrA2
gene. After 6 h the medium was exchanged and cells were allowed to continue
growing at 37 °C. Two days after transfection cells were stained with DRAQ7 and
imaged with an IN Cell analyzer 2000 (GE Healthcare). The fraction of dead (as
indicated by DRAQ7 staining) GFP-positive cells was calculated for each well. At
least 150 GFP-positive cells were counted in each well. Results from each of three
separate biological replicate experiments are plotted individually on Figure 3.
Comparison of HtrA trypsin-like and PDZ domain relative
positions. HtrA structures were downloaded from the Protein Data Bank
(www.rcsb.org) and aligned using specifically their PDZ domains with PyMOL to the
HtrA2 S306A structure.14 If the protein contained multiple PDZ domains, the most
N-terminal one was utilized. All against all pairwise comparisons were made by
measuring the distance between the Cα carbon atoms of the protease active site
serine (or alanine) residue. The data were organized using hierarchical clustering
with complete linkage using MultiDendrograms 5.0.60 Heat maps were generated
with R61 using the heatmap.2 function of the gplots package.62
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements. We would like to thank Professor Margarida Bastos and
Dr. Frederico Silva for assistance with calorimetry, Professor Manuel J.B. Marques
with refractometry, Professor Eduardo Marques and Dr. João Neves with
viscosometry, Dr. Trent Balius with hierarchical clustering, Professor Brian K.
Shoichet with interpreting protein stability measurements, Dr. Hélder Maiato, Dr.
Cristina Ferrás, Dr. Emma Commas-Casellas and Luísa Ferreira for help with cell
culture. Funding to Biomolecular Structure and Function lab was provided by the
project Norte-01-0145-FEDER-000008 – Porto Neurosciences and Neurologic
Disease Research Initiative at I3S, supported by Norte Portugal Regional Operational
Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement,
through the European Regional Development Fund (FEDER). CM, MJR and PAF
acknowledge the financial support from the European Union (FEDER funds POCI/
01/0145/FEDER/007728) and National Funds (FCT/MEC, Fundação para a Ciência e
Tecnologia and Ministério da Educação e Ciência) under the Partnership Agreement
PT2020 UID/MULTI/04378/2013. C.M. is a recipient of a FCT PhD fellowship (SFRH/
BD/84016/2012). M.M. thanks the Fundação para a Ciência e a Tecnologia (FCT) for
its support through the Ciência 2008 program.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps
and institutional affiliations.
1. Clausen T, Kaiser M, Huber R, Ehrmann M. HTRA proteases: regulated proteolysis in
protein quality control. Nat Rev Mol Cell Biol 2011; 12: 152–162.
2. Krojer T, Sawa J, Huber R, Clausen T. HtrA proteases have a conserved activation
mechanism that can be triggered by distinct molecular cues. Nat Struct Mol Biol 2010; 17:
844–852.
3. Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, Lemoine NR et al. The serine
protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol
Chem 2002; 277: 439–444.
4. Figaj D, Gieldon A, Bartczak M, Koper T, Zarzecka U, Lesner A et al. The LD loop as an
important structural element required for transmission of the allosteric signal in the HtrA
(DegP) protease from Escherichia coli. FEBS J 2016; 283: 3471–3487.
5. Singh N, Kuppili RR, Bose K. The structural basis of mode of activation and functional
diversity: a case study with HtrA family of serine proteases. Arch Biochem Biophys 2011;
516: 85–96.
6. Gieldon A, Zurawa-Janicka D, Jarzab M, Wenta T, Golik P, Dubin G et al. Distinct 3D
architecture and dynamics of the human HtrA2(Omi) protease and its mutated variants.
PLoS ONE 2016; 11: e0161526.
7. Martins LM, Turk BE, Cowling V, Borg A, Jarrell ET, Cantley LC et al. Binding specificity and
regulation of the serine protease and PDZ domains of HtrA2/Omi. J Biol Chem 2003; 278:
49417–49427.
8. Walsh NP, Alba BM, Bose B, Gross CA, Sauer RT. OMP peptide signals initiate the
envelope-stress response by activating DegS protease via relief of inhibition mediated by its
PDZ domain. Cell 2003; 113: 61–71.
9. Spiess C, Beil A, Ehrmann M. A temperature-dependent switch from chaperone to protease
in a widely conserved heat shock protein. Cell 1999; 97: 339–347.
10. Zurawa-Janicka D, Jarzab M, Polit A, Skorko-Glonek J, Lesner A, Gitlin A et al. Temperature-
induced changes of HtrA2(Omi) protease activity and structure. Cell Stress Chaperon 2013;
18: 35–51.
11. Hegde R, Srinivasula SM, Zhang ZJ, Wassell R, Mukattash R, Cilenti L et al. Identification of
Omi/HtrA-2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis
protein-caspase interaction. J Biol Chem 2002; 277: 432–438.
12. Mandel H, Saita S, Edvardson S, Jalas C, Shaag A, Goldsher D et al. Deficiency of HTRA2/
Omi is associated with infantile neurodegeneration and 3-methylglutaconic aciduria. J Med
Genet 2016; 53: 690–696.
13. Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, Berg D et al. Loss of
function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet
2005; 14: 2099–2111.
14. Li WY, Srinivasula SM, Chai JJ, Li PW, Wu JW, Zhang ZJ et al. Structural insights into the
pro-apoptotic function of mitochondrial serine protease HtrA2/Omi. Nat Struct Biol 2002; 9:
436–441.
15. Sohn J, Grant RA, Sauer RT. Allostery is an intrinsic property of the protease domain of
DegS: implications for enzyme function and evolution. J Biol Chem 2010; 285: 34039–34047.
16. Sohn J, Grant RA, Sauer RT. OMP peptides activate the DegS stress-sensor protease by a
relief of inhibition mechanism. Structure 2009; 17: 1411–1421.
17. Hasselblatt H, Kurzbauer R, Wilken C, Krojer T, Sawa J, Kurt J et al. Regulation of the sigma
E stress response by DegS: how the PDZ domain keeps the protease inactive in the resting
state and allows integration of different OMP-derived stress signals upon folding stress.
Gene Dev 2007; 21: 2659–2670.
18. Iwanczyk J, Damjanovic D, Kooistra J, Leong V, Jomaa A, Ghirlando R et al. Role of the PDZ
domains in Escherichia coli DegP protein. J Bacteriol 2007; 189: 3176–3186.
19. Murwantoko Yano M, Ueta Y, Murasaki A, Kanda H, Oka C et al. Binding of proteins to the
PDZ domain regulates proteolytic activity of HtrA1 serine protease. Biochem J 2004; 381:
895–904.
20. Wrase R, Scott H, Hilgenfeld R, Hansen G. The Legionella HtrA homologue DegQ is a self-
compartmentizing protease that forms large 12-meric assemblies. Proc Natl Acad Sci USA
2011; 108: 10490–10495.
21. Bejugam PR, Kuppili RR, Singh N, Gadewal N, Chaganti LK, Sastry GM et al. Allosteric
regulation of serine protease HtrA2 through novel non-canonical substrate binding pocket.
Plos ONE 2013; 8: e55416.
Molecular motion regulates the activity of HtrA2
M Merski et al
9
Cell Death and Disease
22. Sohn J, Grant RA, Sauer RT. Allosteric activation of DegS, a stress sensor PDZ protease.
Cell 2007; 131: 572–583.
23. Bagautdinov B, Matsuura Y, Yamamoto H, Sawano M, Ogasahara K, Takehira M et al.
Thermodynamic analysis of unusually thermostable CutA1 protein from human brain and its
protease susceptibility. J Biochem 2015; 157: 169–176.
24. Touw WG, Baakman C, Black J, te Beek TAH, Krieger E, Joosten RP et al. A series of PDB-
related databanks for everyday needs. Nucleic Acids Res 2015; 43: D364–D368.
25. Sekhar A, Latham MP, Vallurupalli P, Kay LE. Viscosity-dependent kinetics of protein
conformational exchange: microviscosity effects and the need for a small viscogen. J Phys
Chem B 2014; 118: 4546–4551.
26. Gerlits O, Keen DA, Blakeley MP, Louis JM, Weber IT, Kovalevsky A. Room temperature
neutron crystallography of drug resistant HIV-1 protease uncovers limitations of X-ray
structural analysis at 100 K. J Med Chem 2017; 60: 2018–2025.
27. Sun RH, Fan HT, Gao F, Lin YJ, Zhang LX, Gong WM et al. Crystal structure of Arabidopsis
Deg2 protein reveals an internal PDZ ligand locking the hexameric resting state. J Biol Chem
2012; 287: 37564–37569.
28. Kim S, Sauer RT. Cage assembly of DegP protease is not required for substrate-dependent
regulation of proteolytic activity or high-temperature cell survival. Proc Natl Acad Sci USA
2012; 109: 7263–7268.
29. Eigenbrot C, Ultsch M, Lipari MT, Moran P, Lin SJ, Ganesan R et al. Structural and functional
analysis of HtrA1 and its subdomains. Structure 2012; 20: 1040–1050.
30. Truebestein L, Tennstaedt A, Moonig T, Krojer T, Canellas F, Kaiser M et al. Substrate-
induced remodeling of the active site regulates human HTRA1 activity. Nat Struct Mol Biol
2011; 18: 386–388.
31. Chaganti LK, Kuppili RR, Bose K. Intricate structural coordination and domain plasticity
regulate activity of serine protease HtrA2. FASEB J 2013; 27: 3054–3066.
32. Jarzab M, Wenta T, Zurawa-Janicka D, Polit A, Gieldon A, Wysocka M et al. Intra- and
intersubunit changes accompanying thermal activation of the HtrA2(Omi) protease
homotrimer. Biochim Biophys Acta 2016; 1864: 283–296.
33. de Regt AK, Kim S, Sohn J, Grant RA, Baker TA, Sauer RT. A conserved activation cluster is
required for allosteric communication in HtrA-family proteases. Structure 2015; 23: 517–526.
34. Schultz SG, Solomon AK. Determination of effective hydrodynamic radii of small molecules
by viscometry. J Gen Physiol 1961; 44: 1189–1199.
35. Ling K, Jiang HY, Zhang QQ. A colorimetric method for the molecular weight determination
of polyethylene glycol using gold nanoparticles. Nanoscale Res Lett 2013; 8: 538.
36. Uribe S, Sampedro JG. Measuring solution viscosity and its effect on enzyme activity. Biol
Proceed Online 2003; 5: 108–115.
37. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap
extension using the polymerase chain-reaction. Gene 1989; 77: 51–59.
38. de Sanctis D, Beteva A, Caserotto H, Dobias F, Gabadinho J, Giraud T et al. ID29: a high-
intensity highly automated ESRF beamline for macromolecular crystallography experiments
exploiting anomalous scattering. J Synchrotron Radiat 2012; 19: 455–461.
39. Battye TG, Kontogiannis L, Johnson O, Powell HR, Leslie AG. iMOSFLM: a new graphical
interface for diffraction-image processing with MOSFLM. Acta Crystallogr D 2011; 67:
271–281.
40. Kabsch W. XDS. Acta Crystallogr D 2010; 66: 125–132.
41. Evans P. Scaling and assessment of data quality. Acta Crystallogr D 2006; 62: 72–82.
42. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N et al. PHENIX: a
comprehensive Python-based system for macromolecular structure solution. Acta Crystal-
logr D 2010; 66: 213–221.
43. Winn MD, Isupov MN, Murshudov GN. Use of TLS parameters to model anisotropic
displacements in macromolecular refinement. Acta Crystallogr D 2001; 57: 122–133.
44. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta
Crystallogr D 2010; 66: 486–501.
45. Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ et al. MolProbity:
all-atom structure validation for macromolecular crystallography. Acta Crystallogr D 2010;
66: 12–21.
46. Mattei P, Kast P, Hilvert D. Bacillus subtilis chorismate mutase is partially diffusion-
controlled. Eur J Biochem 1999; 261: 25–32.
47. Gordon JC, Myers JB, Folta T, Shoja V, Heath LS, Onufriev A. H++: a server for estimating
pKas and adding missing hydrogens to macromolecules. Nucleic Acids Res 2005; 33:
W368–W371.
48. OlssonMH, SondergaardCR, Rostkowski M, Jensen JH. PROPKA3: consistent treatment of internal
and surface residues in empirical pKa predictions. J Chem Theory Comput 2011; 7: 525–537.
49. Case D, Darden T, Cheatham T III, Simmerling C, Wang J, Duke R et al. AMBER 12.
University of California: San Francisco, CA, USA, 2012.
50. Cheatham TE 3rd, Cieplak P, Kollman PA. A modified version of the Cornell et al. force field
with improved sugar pucker phases and helical repeat. J Biomol Struct Dyn 1999; 16:
845–862.
51. Perez A, Marchan I, Svozil D, Sponer J, Cheatham TE 3rd, Laughton CA et al. Refinement of
the AMBER force field for nucleic acids: improving the description of alpha/gamma
conformers. Biophys J 2007; 92: 3817–3829.
52. Zgarbova M, Otyepka M, Sponer J, Mladek A, Banas P, Cheatham TE 3rd et al.
Refinement of the Cornell et al. nucleic acids force field based on reference quantum
chemical calculations of glycosidic torsion profiles. J Chem Theory Comput 2011; 7:
2886–2902.
53. Loncharich RJ, Brooks BR, Pastor RW. Langevin dynamics of peptides: the frictional
dependence of isomerization rates of N-acetylalanyl-N'-methylamide. Biopolymers 1992; 32:
523–535.
54. Berendsen HJ, Postma Jv, van Gunsteren WF, DiNola A, Haak J. Molecular dynamics with
coupling to an external bath. J Chem Phys 1984; 81: 3684–3690.
55. Grossfield A WHAM: the weighted histogram analysis method, version 2.0. 9 http://
membrane.urmc.rochester.edu/content/wham 2013.
56. Martins SA, Perez MA, Moreira IS, Sousa SF, Ramos MJ, Fernandes PA. Computational
alanine scanning mutagenesis: MM-PBSA vs TI. J Chem Theory Comput 2013; 9:
1311–1319.
57. Misin M, Palmer DS, Fedorov MV. Predicting solvation free energies using parameter-free
solvent models. J Phys Chem B 2016; 120: 5724–5731.
58. Woo HJ, Roux B. Calculation of absolute protein-ligand binding free energy from computer
simulations. Proc Natl Acad Sci USA 2005; 102: 6825–6830.
59. Gapsys V, Michielssens S, Seeliger D, de Groot BL. Accurate andrigorous prediction of the
changes in protein free energies in a large-scale mutation scan. Angew Chem Int Ed 2016;
55: 7364–7368.
60. Fernandez A, Gomez S. Solving non-uniqueness in agglomerative hierarchical clustering
using multidendrograms. J Classif 2008; 25: 43–65.
61. Team RCR: A language and environment for statistical computing. R Foundation for
Statistical Computing: Vienna, Austria, 2015.
62. Warnes GR, Bolker B, Bonebakker L, Gentleman R, Huber W, Liaw A et al. gplots: Various R
Programming Tools for Plotting Data. R package version 3.0.12016.
63. Agarwal PK, Billeter SR, Rajagopalan PTR, Benkovic SJ, Hammes-Schiffer S. Network of
coupled promoting motions in enzyme catalysis. Proc Natl Acad Sci USA 2002; 99:
2794–2799.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under a Creative Commons Attribution 4.0 International
License. The images or other third party material in this article are
included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the
Creative Commons license, users will need to obtain permission from
the license holder to reproduce the material. To view a copy of this
license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2017
Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)
Molecular motion regulates the activity of HtrA2
M Merski et al
10
Cell Death and Disease
